NeoTX Therapeutics

Israel
Reẖovot, Central District, Israel, 7670202

Company profile

NeoTX Therapeutics company profile

NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.

Business identity

Phone number
609 718 2305
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
7670202
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$65M
Last funding
Series C / $45M / 2020-02-19
Last equity funding
Series C / $45M
Investors
4
Lead investors
1
Founders
2
Articles
12

Founders and investors

Founders

Asher NathanRobert Harow

Lead investors

Tako Ventures

Investors

J. Tomilson HillMaurice R. GreenbergNDFOSTako Ventures